Clinical Trial Update: D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial of D-cycloserine as an adjunctive treatment for PTSD in adolescents. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Tulane University School of Medicine | Conditions: Posttraumatic Stress Disorder, PTSD | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06